Cullinan Therapeutics has a robust T-cell engager pipeline, savvy management, and a strong cash position. Read more on what investors should know about the company.

Zero-day exploits, AI-driven Android malware, firmware backdoors, password manager trust gaps, rising DDoS define this week’s critical cyber threats.